{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:11:56Z","timestamp":1777515116975,"version":"3.51.4"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T00:00:00Z","timestamp":1410825600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1001713","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T17:49:03Z","timestamp":1410889743000},"page":"e1001713","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":87,"title":["Genetic Predisposition to Increased Blood Cholesterol and Triglyceride Lipid Levels and Risk of Alzheimer Disease: A Mendelian Randomization Analysis"],"prefix":"10.1371","volume":"11","author":[{"given":"Petroula","family":"Proitsi","sequence":"first","affiliation":[]},{"given":"Michelle K.","family":"Lupton","sequence":"additional","affiliation":[]},{"given":"Latha","family":"Velayudhan","sequence":"additional","affiliation":[]},{"given":"Stephen","family":"Newhouse","sequence":"additional","affiliation":[]},{"given":"Isabella","family":"Fogh","sequence":"additional","affiliation":[]},{"given":"Magda","family":"Tsolaki","sequence":"additional","affiliation":[]},{"given":"Makrina","family":"Daniilidou","sequence":"additional","affiliation":[]},{"given":"Megan","family":"Pritchard","sequence":"additional","affiliation":[]},{"given":"Iwona","family":"Kloszewska","sequence":"additional","affiliation":[]},{"given":"Hilkka","family":"Soininen","sequence":"additional","affiliation":[]},{"given":"Patrizia","family":"Mecocci","sequence":"additional","affiliation":[]},{"given":"Bruno","family":"Vellas","sequence":"additional","affiliation":[]},{"name":"for the Alzheimer's Disease Neuroimaging Initiative","sequence":"additional","affiliation":[]},{"given":"Julie","family":"Williams","sequence":"additional","affiliation":[]},{"name":"for the GERAD1 Consortium","sequence":"additional","affiliation":[]},{"given":"Robert","family":"Stewart","sequence":"additional","affiliation":[]},{"given":"Pak","family":"Sham","sequence":"additional","affiliation":[]},{"given":"Simon","family":"Lovestone","sequence":"additional","affiliation":[]},{"given":"John F.","family":"Powell","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2014,9,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11883-012-0307-3","article-title":"Dyslipidemia and the risk of Alzheimer's disease","volume":"15","author":"C Reitz","year":"2013","journal-title":"Curr Atheroscler Rep"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/153331750502000208","article-title":"Cholesterol and apolipoprotein E in Alzheimer's disease","volume":"20","author":"AB Reiss","year":"2005","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrn3012","article-title":"Linking lipids to Alzheimer's disease: cholesterol and beyond","volume":"12","author":"PG Di","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease","volume":"41","author":"D Harold","year":"2009","journal-title":"Nat Genet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng.803","article-title":"Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease","volume":"43","author":"P Hollingworth","year":"2011","journal-title":"Nat Genet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.neurobiolaging.2010.11.022","article-title":"Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations","volume":"32","author":"JC Lambert","year":"2011","journal-title":"Neurobiol Aging"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1212\/01.WNL.0000149519.47454.F2","article-title":"Midlife cardiovascular risk factors and risk of dementia in late life","volume":"64","author":"RA Whitmer","year":"2005","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.7326\/0003-4819-137-3-200208060-00006","article-title":"Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease","volume":"137","author":"M Kivipelto","year":"2002","journal-title":"Ann Intern Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000231980","article-title":"Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later","volume":"28","author":"A Solomon","year":"2009","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jalz.2006.02.003","article-title":"Statin use and the risk of Alzheimer's disease: the MIRAGE study","volume":"2","author":"RC Green","year":"2006","journal-title":"Alzheimers Dement"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/01.WNL.0000160114.42643.31","article-title":"APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study","volume":"64","author":"C Dufouil","year":"2005","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/jech.2009.100826","article-title":"Statins and serum cholesterol's associations with incident dementia and mild cognitive impairment","volume":"65","author":"MA Beydoun","year":"2011","journal-title":"J Epidemiol Community Health"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1212\/WNL.0b013e3181feb2bf","article-title":"The 32-year relationship between cholesterol and dementia from midlife to late life","volume":"75","author":"MM Mielke","year":"2010","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archinte.163.9.1053","article-title":"Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study","volume":"163","author":"ZS Tan","year":"2003","journal-title":"Arch Intern Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1001\/archneur.64.1.103","article-title":"Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study","volume":"64","author":"R Stewart","year":"2007","journal-title":"Arch Neurol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1212\/WNL.0b013e3181d6476a","article-title":"Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe","volume":"74","author":"HH Feldman","year":"2010","journal-title":"Neurology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jalz.2008.02.001","article-title":"The Atorvastatin\/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics","volume":"4","author":"RW Jones","year":"2008","journal-title":"Alzheimers Dement"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1212\/WNL.0b013e318228bf11","article-title":"A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease","volume":"77","author":"M Sano","year":"2011","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels","volume":"45","author":"CJ Willer","year":"2013","journal-title":"Nat Genet"},{"key":"ref21","first-page":"359","article-title":"Biomarkers for disease modification trials\u2013the innovative medicines initiative and AddNeuroMed","volume":"11","author":"S Lovestone","year":"2007","journal-title":"J Nutr Health Aging"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"G McKhann","year":"1984","journal-title":"Neurology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng1653","article-title":"Population structure, differential bias and genomic control in a large-scale, case-control association study","volume":"37","author":"DG Clayton","year":"2005","journal-title":"Nat Genet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000092553","article-title":"Effects of differential genotyping error rate on the type I error probability of case-control studies","volume":"61","author":"V Moskvina","year":"2006","journal-title":"Hum Hered"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"S Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1371\/journal.pgen.0020190","article-title":"Population structure and eigenanalysis","volume":"2","author":"N Patterson","year":"2006","journal-title":"PLoS Genet"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/978-1-60327-367-1_19","article-title":"Quality control for genome-wide association studies","volume":"628","author":"ME Weale","year":"2010","journal-title":"Methods Mol Biol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e1000529","DOI":"10.1371\/journal.pgen.1000529","article-title":"A flexible and accurate genotype imputation method for the next generation of genome-wide association studies","volume":"5","author":"BN Howie","year":"2009","journal-title":"PLoS Genet"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1093\/bioinformatics\/btn564","article-title":"SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap","volume":"24","author":"AD Johnson","year":"2008","journal-title":"Bioinformatics"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.annepidem.2006.12.005","article-title":"Re: Estimation of bias in nongenetic observational studies using \u201cMendelian triangulation\u201d by Bautista, et al","volume":"17","author":"DC Thomas","year":"2007","journal-title":"Ann Epidemiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/aje\/kwt084","article-title":"Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators","volume":"178","author":"BL Pierce","year":"2013","journal-title":"Am J Epidemiol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"S Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"TM Teslovich","year":"2010","journal-title":"Nature"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/archneurol.2011.203","article-title":"Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies","volume":"68","author":"NE Shepardson","year":"2011","journal-title":"Arch Neurol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1212\/01.wnl.0000256368.57375.b7","article-title":"Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study","volume":"68","author":"A Solomon","year":"2007","journal-title":"Neurology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1001\/jamaneurol.2013.5390","article-title":"Associations between serum cholesterol levels and cerebral amyloidosis","volume":"71","author":"B Reed","year":"2014","journal-title":"JAMA Neurol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00439-007-0448-6","article-title":"Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology?","volume":"123","author":"S Ebrahim","year":"2008","journal-title":"Hum Genet"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology","volume":"27","author":"DA Lawlor","year":"2008","journal-title":"Stat Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/1831654a0","article-title":"Canalization of development and genetic assimilation of acquired characters","volume":"183","author":"CH Waddington","year":"1959","journal-title":"Nature"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00041433-200104000-00003","article-title":"Cholesterol metabolism in the brain","volume":"12","author":"JM Dietschy","year":"2001","journal-title":"Curr Opin Lipidol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2147\/VHRM.S1839","article-title":"Vascular risk factors, cognitive decline, and dementia","volume":"4","author":"E Duron","year":"2008","journal-title":"Vasc Health Risk Manag"}],"container-title":["PLoS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1001713","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:07:32Z","timestamp":1540339652000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1001713"}},"subtitle":[],"editor":[{"given":"Davey Smith","family":"George","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2014,9,16]]},"references-count":41,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1001713","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,16]]}}}